CLINICAL_TRIALS
trial_result
· 2014-08-06
Clinical Trial Update: A Six Week, Double-Blind Randomized, Efficacy and Safety, Sleep Lab Trial With Esmirtazapine (Org 50081) (P05707) [Phase 3]
Summary
Phase 3 double-blind trial evaluating esmirtazapine (Org 50081) for efficacy and safety in insomnia; results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Insomnia | Phase 3 | Status: COMPLETED | Results posted: 2014-08-06